MetLife Russell 2000 Index Portfolio HALO Holdings History
MetLife Russell 2000 Index Portfolio's Halozyme Therapeutics Inc Holding Summary
As of 2025-03-31, Brighthouse Funds Trust II held 43,608.00 shares of Halozyme Therapeutics Inc(HALO), totaling $2.78 Mil. This investment constitutes 0.32% of their stock portfolio, and Brighthouse Funds Trust II now holds 0.04% of the outstanding Halozyme Therapeutics Inc(HALO) stock.
The initial trade took place in 2019Q3. And since then MetLife Russell 2000 Index Portfolio has made 3 purchases of HALO, at an average price of $19.15, for a total of 72,465.00 shares. In addition, there have been 9 sales at an average price of $35.68 for 28,857.00 shares. Based on historical transaction data and HALO's current price of $57.81, MetLife Russell 2000 Index Portfolio's estimated gain on his HALO holdings is $2.16 Mil, reflecting a 155.85% gain to date.
MetLife Russell 2000 Index Portfolio HALO ($57.81) Holding Chart
MetLife Russell 2000 Index Portfolio HALO ($57.81) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
